Granahan Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Granahan Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-66,875	Closed	-$1.59M	–	260
2016 Q3	$1.59M	Sell	66,875 -147,354	-69%	-$2.78M	0.05%	187
2016 Q2	$3.43M	Sell	214,229 -5,570	-3%	-$99.9K	0.12%	169
2016 Q1	$4.6M	Sell	219,799 -18,090	-8%	-$323K	0.17%	159
2015 Q4	$6.42M	Buy	237,889 +25,541	+12%	+$696K	0.22%	139
2015 Q3	$5.9M	Buy	212,348 +88,131	+71%	+$2.78M	0.18%	169
2015 Q2	$3.04M	Sell	124,217 -17,430	-12%	-$359K	0.09%	200
2015 Q1	$2.59M	Sell	141,647 -52,931	-27%	-$1.07M	0.07%	205
2014 Q4	$3.59M	Buy	+194,578	New	+$2.31M	0.1%	176

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Granahan Investment Management's LJPC Position: Q4 2016 in Review

Granahan Investment Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2016, closing a stake of 66,875 shares — an estimated $1.59M sold.

Granahan Investment Management first reported a position in LJPC in Q4 2014 and held it in 8 quarters. The position peaked at $6.42M in Q4 2015. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

Granahan Investment Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2016 after selling out during the quarter.
Granahan Investment Management sold 66,875 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $1.59M.
Granahan Investment Management first reported a position in La Jolla Pharmaceutical Company in Q4 2014 and held it in 8 quarters.
Granahan Investment Management's La Jolla Pharmaceutical Company position peaked at $6.42M in Q4 2015.
62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on Granahan Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.